After many months of strategic planning and growth, the 2 firms are able to announce the small print of their upcoming acquisition deal.
Minsk, Belarus., June 23, 2022 (GLOBE NEWSWIRE) — Defend Pharmaceutical Company, Inc. “OTC:(PRTT)” will enter right into a share change settlement with СJSC “Inaiapp” (a number one blockchain options supplier in EU area) as a way to safe its strategic targets for the net 3.0 market. The settlement is to accumulate 100% of the excellent shares of Inaiapp. Inaiapp has a particularly sturdy growth and administration workforce that may carry instantaneous important worth to PRTT.
The deal will drive PRTT’s place as an rising tech innovation firm and permit the consolidation of monetary flows required to develop and launch its premier merchandise (multiboxnft.com and others) based on firm intentions and targets.
“We not solely level out the apparent worth, that Inaiapp will carry to PRTT, but in addition the influence, that public buying and selling firm might create with Inaiapp’s property”, says Nick Greb President of Defend Pharmaceutical Company, Inc.
Established in 2014, Inaiapp has 8 years of blockchain growth expertise, serving to companies develop. The corporate brings excessive finish enterprise automation and DLT-based instruments, providing distinctive speeds, fixed knowledge integrity, excessive safety and scalability to its shoppers.
Defend Pharmaceutical Company is a full-cycle software program growth and supply firm that produces, releases, and helps digital merchandise for the business-to-business and business-to-consumer markets. The corporate’s experience lies in customized software program growth and consulting companies in Enterprise automation, Synthetic Intelligence, Machine Studying, Information Science, Huge Information, Picture recognition, Blockchain growth, and cloud companies. Its area focus contains Provide chain, Logistics, Healthcare, Finance, Actual property, Authorized, Insurance coverage, Promoting, and extra.
For extra info contact:
Defend Pharmaceutical Corporation, Inc.
(347) 692 8942